Selling Buzz: Inhibrx Biosciences Inc [INBX] 10% Owner VIKING GLOBAL INVESTORS LP sells 350,000 shares of the company

Jaxson Clark

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Inhibrx Biosciences Inc shares valued at $11,287,500 were sold by VIKING GLOBAL INVESTORS LP on Oct 07 ’25. At $32.25 per share, VIKING GLOBAL INVESTORS LP sold 350,000 shares. The insider’s holdings dropped to 67,018 shares worth approximately $5.16 million following the completion of this transaction.

Also, Kayyem Jon Faiz purchased 69,686 shares, netting a total of over 991,416 in proceeds. Following the buying of shares at $14.23 each, the insider now holds 51,093 shares.

Before that, Kayyem Jon Faiz had added 37,500 shares to its account. In a trade valued at $532,204, the Director bought Inhibrx Biosciences Inc shares for $14.19 each. Upon closing the transaction, the insider’s holdings increased to 37,500 shares, worth approximately $5.38 million.

As published in their initiating research note from JMP Securities on July 23, 2024, Inhibrx Biosciences Inc [INBX] has been a Mkt perform.

Analyzing INBX Stock Performance

On last trading session, Inhibrx Biosciences Inc [NASDAQ: INBX] rose 12.50% to $77.05. The stock’s lowest price that day was $67.67, but it reached a high of $77.5651 in the same session. During the last five days, there has been a surge of approximately 144.45%. Over the course of the year, Inhibrx Biosciences Inc shares have jumped approximately 401.30%. Shares of the company reached a 52-week high of $77.57 on 10/29/25 and a 52-week low of $10.81 on 04/11/25.

Support And Resistance Levels for Inhibrx Biosciences Inc (INBX)

According to the 24-hour chart, there is a support level at 70.62, which, if violated, would cause prices to drop to 64.20. In the upper region, resistance lies at 80.52. The next price resistance is at 83.99. RSI (Relative Strength Index) is 83.90 on the 14-day chart, showing overbought technical sentiment.

Is Inhibrx Biosciences Inc subject to short interest?

Stocks of Inhibrx Biosciences Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.19 million shares to 0.53 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 0.72 million shares. A decline of -35.45% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.44 of the overall float, the days-to-cover ratio (short ratio) decline to 3.44.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.